Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.

John F Modlin ,Kristin L Nichol ,T R Graydon ,David J Brooks ,W P Mckinney ,M.c Myers ,James E Cheek ,Georges Peter ,H R Wilson ,D R Johnson ,Margaret B Rennels ,David A Ashford ,B M Word ,Federico Guerra ,Stanley A Gall ,William Schaffner ,Victor Marchessault ,Lauren Tompkins ,Carl B Heilman ,Gary A Evans ,Paul A Offit ,Jon S Abramson ,Richard D Clover ,Robert B Jackson ,Karen Midthun ,José E P Santos ,R T Snider ,Chap T Le ,Larry K Pickering ,C R Helms ,Samuel L Katz ,Peter Gardner ,Michael J Mahoney ,B J Howe ,Jan Siegel ,D Bradshaw ,L D Rotz

doi:10.1081/clt-100102886

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.

John F Modlin , Kristin L Nichol + Show 35 more

https://doi.org/10.1081/clt-100102886

Copy DOI

Journal: Clinical toxicology (Philadelphia, Pa.)	Publication Date: Jan 1, 2001
Citations: 47

Affiliation: Dartmouth College, Dartmouth Hospital

#Use Of Anthrax Vaccine #Use Of Aluminum Hydroxide + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.

Full Text